Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (575)	1/27/2005 1:49:55 PM
From: richardred	Read Replies (3) \| Respond to of 7254

I agree, but I won't be selling my shares! Lannett Company Announces Stock Repurchase Program Thursday January 27, 7:55 am ET PHILADELPHIA, Jan. 27 /PRNewswire-FirstCall/ -- Lannett Company, Inc. (Amex: LCI - News) today announced that its board of directors has authorized a stock repurchase program. The program authorizes management, at its discretion, to repurchase up to $5 million of the company's outstanding common stock from time to time. The repurchases may be made through open market or privately negotiated transactions. "The repurchase program reflects the board's belief that, at current prices, Lannett shares represent an attractive long-term investment for the company and its shareholders," said Arthur Bedrosian, president of Lannett. Please contact Robert Jaffe or Rob Whetstone at PondelWilkinson Inc. with more questions at 310/279-5980. About Lannett Company: Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit Lannett Company's website at lannett.com . This news release contains certain statements of a forward-looking nature relating to future events or future business performance. Any such statements including, but not limited to, Lannett's shares representing an attractive long-term investment, Lannett's estimated or anticipated future financial results, future inventory levels, future competition or pricing, future levels of operating expenses, product development efforts or performance, or other non-historical facts are forward-looking and reflect Lannett's current perspective of existing trends and information. These statements involve risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. For other risks and uncertainties, please refer to Lannett's most recent filings with the Securities and Exchange Commission, including but not limited to: Lannett's Annual Report and Form 10-K for the year ended June 30, 2004. biz.yahoo.com

To: richardred who wrote (575)	3/27/2005 11:02:51 PM
From: richardred	Read Replies (1) \| Respond to of 7254

Perrigo to integrate Agis before more acquisitions Mon Mar 21, 2005 06:41 AM ET By Steven Scheer TEL AVIV, March 21 (Reuters) - U.S. generic drugmaker Perrigo Co. (PRGO.O: Quote, Profile, Research) said on Monday it would consider making further acquisitions after it completes the integration of Israel's Agis Industries. Perrigo to integrate Agis before more acquisitions "We have good cash flow to support finding other acquisitions in the near future but our focus is integrating Agis into Perrigo and taking advantage of what we just bought," Perrigo Chairman, President and Chief Executive Officer David Gibbons said. yahoo.reuters.com